Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
SLC4A1	AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR	ENSG00000004939	Solute carrier family 4 member 1 (Diego blood group)	P02730	17	44248385-44268141	Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Anion exchange, Ion transport, Transport	Blood group antigen	Disease mutation, Elliptocytosis, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 95.7;placenta: 32.7	Cell type enriched	Detected in some	66	Erythroid cells: 1261.4	Cancer enriched	Detected in single	91	renal cancer: 16.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Region enhanced	Detected in single		cerebellum: 0.4	Low region specificity	Detected in all			HPA015584, CAB034438, HPA063911	Enhanced								160000000			CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151	unprognostic (1.36e-1)	unprognostic (1.42e-1)	unprognostic (3.36e-1)	unprognostic (2.44e-2)	unprognostic (2.32e-2)	unprognostic (1.56e-2)	unprognostic (1.55e-1)	unprognostic (1.59e-1)	unprognostic (1.68e-1)	unprognostic (1.58e-1)	unprognostic (6.72e-3)	unprognostic (1.19e-1)	unprognostic (9.28e-3)	unprognostic (1.93e-2)	unprognostic (2.18e-1)	unprognostic (1.94e-1)	unprognostic (2.13e-1)	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0	1	8.4	0.1	0.3	0	0.7	1.9	0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.5	1.4	1.7	0.6	0.7	1	0.3	0.4	0.3	0.8	1.4	3.2	0.7	0.6	0.3	0.4	1.4	0.5	0.5	1.1	1.3	1.3	1.7	1.6	2.2	0	0.8	2.3	0.8	0.5	0.8	0.8	0.5	0.2	0.6	4.8	3.5	0.4	0.6	1	3.5	0.9	0.7	0.5	2.5	0.7	1.9	0.3	0.8	2.2	1	1.3	1.4	0.5	0.7	2.5	1.8	1	2.4	2.1	1.4	1.4	1	2.3	1.1	1.6	2.2	1.1	6.1	1	2	1.1	0.9	1	1.1	1	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0	6	1.1	0	0.9	0	0.4	0.7	0	0	1.2	19.2	0	0.3	3.3	0	0.5	0	0	1261.4	0	0.9	0.3	0.4	0	0	1.3	0	0	0.6	0.3	0	0	0	0	0	0	0.2	0	0	0.4	0.2	0	0	0.2	0.9	0.4	0	0.7	0	0	0.5	Erythroid cells
HBQ1	HBQ	ENSG00000086506	Hemoglobin subunit theta 1	P09105	16	180453-181181	Predicted intracellular proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7	Cell type enriched	Detected in some	8	Erythroid cells: 303.7	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Group enriched	Detected in many	6	granulocytes: 2.5;T-cells: 2.3	Group enriched	Detected in some	7	HEL: 13.4;Hep G2: 9.4;K-562: 33.1					Low region specificity	Detected in all			HPA062473	Enhanced		Approved	Lipid droplets					47000	Lipid droplets		HPA062473: AB_2684774		unprognostic (4.24e-1)	unprognostic (3.38e-1)	unprognostic (2.11e-2)	unprognostic (2.20e-2)	unprognostic (1.30e-1)		unprognostic (1.28e-1)	unprognostic (1.48e-1)	unprognostic (1.75e-2)	unprognostic (2.33e-1)	unprognostic (8.92e-2)	unprognostic (2.02e-3)	unprognostic (8.24e-2)	unprognostic (1.68e-1)	unprognostic (1.02e-1)	unprognostic (5.55e-1)	0.5	0.6	12.2	0.5	10	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0	0.5	0	0.5	0.6	10.7	0.4	0.2	2.5	0	0	2.3	8	0	0.8	0.2	2.5	0	0	0.4	0.1	0	0	0.1	2.3	0	0	0.3	0	0	0.1	0.9	0	0	0	0	13.4	0.5	9.4	0	0.1	0	0.3	0	0	0	0	0.1	0.8	33.1	0	0	0.1	1.4	0	1.8	0	0.1	0.1	0	0.2	0.5	0	0.3	1.8	0	0	0.3	0	0	0.5	0.2	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	2.1	0	2.3	0.4	0.7	1.6	0.1	0	0.5	1.2	2.5	0	0	0.2	0	8	12.2	10	0.6	6.3	5.6	4	2.2	3.7	2.4	0.3	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0.9	0	0	303.7	0	1.7	0	0	0	0	0.4	0	0	0	0.3	2.5	0.3	0	3.3	0	0	0	0	0	0	0.2	0	0	0.1	3.8	40.3	0.1	0.2	0	0	0	Erythroid cells
KIF4A	FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100	ENSG00000090889	Kinesin family member 4A	O95239	X	70290090-70420832	Predicted intracellular proteins		DNA-binding, Motor protein	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 11.1;lymphoid tissue: 19.3	Cell type enriched	Detected in some	5	Erythroid cells: 46.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		T-reg: 3.2	Lineage enriched	Detected in single	5	T-cells: 3.2	Low cell line specificity	Detected in many											HPA034745, HPA034746, HPA061583	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm, Midbody		HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564	unprognostic (8.17e-3)	unprognostic (2.78e-2)	unprognostic (1.02e-2)	unprognostic (3.46e-3)	unprognostic (3.20e-1)	unprognostic (1.64e-1)	prognostic unfavorable (7.37e-6)	unprognostic (2.18e-3)	unprognostic (5.06e-3)	unprognostic (1.34e-1)	prognostic unfavorable (9.44e-6)	unprognostic (3.79e-2)	unprognostic (0.00e+0)	unprognostic (3.09e-2)	unprognostic (1.10e-1)	unprognostic (1.09e-1)	unprognostic (1.47e-1)	0.9	0.6	0.8	3.3	1	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2	0.7	0	0	0.2	0.2	3.2	0.3	22.5	15.8	23.9	11.7	1.1	2	9.4	17.2	9.2	23.5	20.5	17.7	13.3	13.9	10.8	8.4	18.2	13.6	25.8	9.3	26.6	15.9	13	15.7	19.3	12.5	0.2	17.4	10.9	0.7	0.5	19.5	11.2	2.8	14.3	10.7	19.9	30.9	22.1	14.5	15.9	8.6	24.1	24.1	16.8	17.7	32.3	13	5.6	8.9	15.8	13.2	28	11.9	7.3	12.6	9.5	6.8	9.9	15.6	20.3	16.7	20.4	8.9	15.3	20.1	8.2	19.1	23.4	0	0	0	0	0	0.1	0.7	0.4	1.3	0	0	0.1	0	0	0.2	0.2	0	3.2	0.3	0.8	1	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1	0	0.3	0	0.2	1.5	0	0.4	2.5	0	0	0	0	1.1	0	0	0.3	0.1	0.1	46.7	0	10.3	1	0.1	0	0	4.3	0	1.2	1.8	0.6	0.5	0	0.9	0	0	1.2	2.4	0.1	0	0	0	0	0	0.2	7.2	5.8	0.3	1.5	0.5	2.1	0.3	Erythroid cells
POLA1	NSX, p180, POLA	ENSG00000101868	DNA polymerase alpha 1, catalytic subunit	P09884	X	24693919-24996986	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins	DNA replication, Host-virus interaction	DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase	Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Erythroid cells: 46.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002947, CAB012274	Supported		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	CAB012274: , HPA002947: AB_1079652	unprognostic (6.92e-2)	unprognostic (4.43e-3)	unprognostic (3.27e-3)	unprognostic (1.53e-2)	unprognostic (2.53e-1)	unprognostic (1.49e-1)	prognostic unfavorable (4.80e-5)	unprognostic (1.87e-1)	unprognostic (9.25e-3)	unprognostic (2.48e-2)	unprognostic (8.41e-2)	unprognostic (7.42e-2)	unprognostic (2.09e-1)	unprognostic (1.44e-1)	unprognostic (3.66e-2)	unprognostic (3.48e-2)	unprognostic (3.08e-1)	10.5	5.5	8	15	10.2	14.3	10.9	12	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9	7.9	5.7	10	30.1	7	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8	9.9	19.3	5.9	13.7	9.6	9	17.3	37	13.8	4.2	9.4	12.8	7.9	12.6	6	5.7	16.3	11.8	5.9	4.6	10.2	7	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0	2	1.2	3	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8	10.2	12	9.6	7.8	6.6	10.3	4.5	8.7	10	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0	9.4	11.4	1.8	2	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0	1.8	3.7	4.5	1.3	0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2	Erythroid cells
KLF1	EKLF	ENSG00000105610	Kruppel like factor 1	Q13351	19	12884422-12887199	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0	Cell type enriched	Detected in some	146	Erythroid cells: 350.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9	Lineage enriched	Detected in single	8	monocytes: 4.7	Group enriched	Detected in some	28	HEL: 23.1;K-562: 55.4	Not detected	Not detected			Not detected	Not detected			HPA051850	Enhanced		Supported	Nucleoplasm						Nucleoplasm		HPA051850: AB_2616460	unprognostic (1.17e-1)	unprognostic (1.38e-4)	unprognostic (2.96e-1)	unprognostic (1.17e-3)	unprognostic (7.13e-2)	unprognostic (3.90e-4)	unprognostic (3.25e-2)	unprognostic (3.19e-2)	unprognostic (1.97e-1)	unprognostic (1.08e-2)	unprognostic (6.51e-2)	unprognostic (7.71e-2)	unprognostic (2.69e-3)	unprognostic (1.05e-1)	unprognostic (1.06e-1)	unprognostic (3.76e-1)	unprognostic (2.44e-1)	0	0	0.5	0	0.3	30.6	0	0.1	0.4	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0.1	0.1	1	0.9	0	0.2	0	0	0	0	0.2	9	0.3	0	0	0	0.1	0	0.5	0	0	0	0.1	7	0	0.1	0	0	0.8	1.2	0	0.6	0	0.3	0.5	0.5	4.7	0	0.2	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	23.1	0	0	0	0.3	0.3	0	0	0	0	0	0	0	55.4	0	0	0	0.1	0.1	0.3	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0.3	0.1	0	0	1.3	0	0	1.7	0	0.2	4.7	0	0.3	0	0.1	0.5	0.1	0.1	0.2	0.5	0	2.9	0	0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0	0.3	0	0	0	2.2	0.1	0.1	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	350.4	0	1.2	0	0.2	0	0	2.2	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0	Erythroid cells
RHAG	CD241, RH50A, SLC42A1	ENSG00000112077	Rh associated glycoprotein	Q02094	6	49605158-49636884	CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ammonia transport, Transport		Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	bone marrow: 54.1	Cell type enriched	Detected in some	50	Erythroid cells: 116.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	190	HEL: 87.8;K-562: 86.5	Not detected	Not detected			Not detected	Not detected			HPA046051, HPA055331	Approved		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA046051: , HPA055331: AB_2682785					unprognostic (8.16e-2)						unprognostic (6.86e-2)	unprognostic (1.25e-3)		unprognostic (1.65e-1)				1.2	0.2	0	1.1	0.5	54.1	3.2	0	0.1	2.3	1	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0	0	0.1	0.7	3.3	0.1	0	0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0	0.2	0.5	0.4	0.1	0.9	0.1	0	4.5	0.6	0.2	0	1.7	1.8	0	0.1	0.8	2.8	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	87.8	0	0	0	0	0	0	0	0	0	0	0	0	86.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.5	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.2	0	0	116.8	0.2	0.3	0	0	2.3	0	0.4	0	0	1.8	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Erythroid cells
TSPO2	BZRPL1, dJ34B21.2	ENSG00000112212	Translocator protein 2	Q5TGU0	6	41042554-41044337	Predicted intracellular proteins, Predicted membrane proteins	Transport	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	bone marrow: 32.4	Cell type enriched	Detected in some	84	Erythroid cells: 210.2	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	OE19: 15.8	Not detected	Not detected			Low region specificity	Detected in all			HPA060691, HPA066996			Approved	Plasma membrane						Plasma membrane		HPA060691: , HPA066996: AB_2685761	unprognostic (1.89e-3)	unprognostic (8.35e-3)	unprognostic (2.57e-3)	unprognostic (2.29e-2)	unprognostic (1.63e-1)	unprognostic (2.66e-2)	unprognostic (6.61e-3)	unprognostic (2.29e-1)	unprognostic (3.37e-1)	unprognostic (2.89e-1)	unprognostic (2.71e-1)	unprognostic (4.92e-2)	unprognostic (1.86e-2)	unprognostic (2.70e-2)	unprognostic (1.16e-1)	unprognostic (5.37e-2)	unprognostic (1.76e-2)	0.1	0	0.1	0.1	0.1	32.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0	0.4	0.1	0.1	0	1.3	2.5	0.4	0.1	0.1	0.1	0.1	0.4	0	0.1	0.9	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	1.3	0.1	3.3	4.5	1.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0	0.1	0	0.4	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0	2.3	0	0.1	0.4	0	0	0	0	0	0.1	0.3	0.2	0	0	1.5	0	0.1	0.1	0	0	0	0	0	0	0.6	0.2	0.1	0	0.3	0.2	0.5	0	15.8	0	0.4	0	0	0.3	0.1	0.5	0.2	0	0	0	0.1	0	0.2	0	0	0.1	0.4	0.2	0.8	0.2	0.2	0	0.4	0.1	0	0.1	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	2.5	0	0	0	0	0.1	0	0.7	0.3	0	0.3	210.2	0.8	0.1	0	0	0	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1.4	0	0	0	0	0	0	0.3	0	0	0	Erythroid cells
FAM117A		ENSG00000121104	Family with sequence similarity 117 member A	Q9C073	17	49710332-49789180	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Erythroid cells: 93.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 24.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/70: 35.4;U-266/84: 24.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA022531	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA022531: AB_2101087	prognostic favorable (5.30e-5)	unprognostic (8.06e-3)	unprognostic (2.82e-2)	unprognostic (1.77e-2)	unprognostic (2.00e-1)	unprognostic (3.90e-3)	unprognostic (1.69e-1)	prognostic favorable (8.25e-7)	unprognostic (4.05e-1)	unprognostic (3.58e-1)	prognostic favorable (1.81e-4)	unprognostic (1.99e-2)	unprognostic (3.73e-2)	unprognostic (9.12e-2)	unprognostic (1.45e-1)	unprognostic (4.07e-2)	unprognostic (4.66e-2)	9.9	5.7	7.6	15.5	9.4	42.9	9.6	12.4	5.7	17.4	15.8	5.6	12.2	7.2	21.2	9.6	11.3	12.4	13.3	12.5	5.6	3.7	8.3	10	9	14.2	2.8	5.4	16	17.6	8.6	11.9	4.4	10.8	16.4	6	24.3	11.9	21.3	4	13.6	13.7	20.7	2.1	26.7	10.3	18.4	3.6	30	14.2	6.5	24.1	21.8	8.5	13.9	2.1	24.3	0.9	6.7	5.5	1.8	3	0.7	4.9	0	2.2	0.4	8.8	1	1.7	1.8	3.1	21.7	5	14.3	5.4	0.6	8.3	1.7	3.8	3.6	1.4	1	6.2	15.8	0	6.9	2.4	2.4	12.6	2.1	3	3.1	1.7	1.9	3.3	12.4	19.2	12.2	1.7	8.1	15.2	12.7	7.3	4.1	2.4	4.8	4.1	7.5	2.8	2.7	4.9	3.2	1	0.4	3.5	5	7.2	9.1	0.3	1.8	1.5	1.9	0.8	35.4	24.3	9.5	1.6	3.5	1.5	24.3	0.9	4.9	5	0.6	5.5	13.9	3.3	4.2	0.7	9.3	2.7	3.7	1.9	6.7	0.1	2.1	3.2	1.8	7.6	9.4	12.4	5.7	5.6	3.7	2.8	5.4	10.8	3.6	6	5.7	11	1.2	8	12.6	16.1	2.5	1.4	5.7	7	13.7	0.9	5	1.3	2.3	6.5	0.9	93.5	3.1	1.6	6.1	2.6	2.3	5	1.1	4.8	10.3	6.7	3.2	4.5	13.3	3.4	6.8	11.8	4.4	3.9	3.2	0	14.5	2.8	3.1	0	7.2	17.2	12.4	12.3	0.7	13.1	2.6	0.9	Erythroid cells
CA1	Car1	ENSG00000133742	Carbonic anhydrase 1	P00915	8	85327608-85379014	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 156.0;intestine: 203.6	Cell type enriched	Detected in some	19	Erythroid cells: 11890.7	Group enriched	Detected in some	10	colorectal cancer: 3.4;stomach cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	1207	HEL: 169.2	Low region specificity	Detected in single			Not detected	Not detected			HPA006558, CAB025790	Enhanced								7800000000			CAB025790: , HPA006558: AB_1845989	unprognostic (1.44e-1)	unprognostic (7.56e-2)	unprognostic (1.70e-1)	unprognostic (3.57e-3)	unprognostic (2.08e-2)	unprognostic (1.66e-1)	unprognostic (2.84e-2)	unprognostic (2.03e-2)		unprognostic (1.73e-2)	unprognostic (6.12e-2)	unprognostic (1.63e-1)	unprognostic (1.04e-1)	unprognostic (5.61e-2)	unprognostic (3.01e-2)	unprognostic (2.38e-1)	unprognostic (3.95e-2)	1.8	0.4	0.5	11.5	0.5	156	0.4	0.3	0.4	0.3	95.4	1.5	0	0	0.3	0	0.6	0.7	0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0	0.8	0.5	0	1	24	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0	0.2	7.5	0	0.2	4.5	16	0.7	0.7	0	0.3	0	0.1	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	169.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0.7	0	0	0.3	0.3	0	0	0	0	0	0.7	0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0	0.6	0	0	0	1.5	0	0	0	0.3	0	0	0	0	0	0	0	0	0.4	0	624.8	11890.7	0	0	0	0.1	23	0.6	0	0	44	1.3	1.6	0	0	0	0	0	89.9	0	0	422.3	0	0	0	0	0	0	0	0	0	0	79.4	0	Erythroid cells
CMPK2	NDK, TYKi, UMP-CMPK2	ENSG00000134326	Cytidine/uridine monophosphate kinase 2	Q5EBM0	2	6840570-6866635	Enzymes, Predicted intracellular proteins	Pyrimidine biosynthesis	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria						Mitochondria	Nucleoplasm	HPA041430: AB_10796674	unprognostic (2.37e-1)	unprognostic (6.07e-2)	unprognostic (5.71e-2)	prognostic unfavorable (4.71e-4)	unprognostic (1.82e-1)	unprognostic (5.08e-2)	unprognostic (3.80e-2)	unprognostic (8.93e-2)	unprognostic (6.63e-2)	unprognostic (4.54e-3)	unprognostic (7.39e-3)	unprognostic (1.43e-1)	unprognostic (1.09e-3)	unprognostic (1.28e-1)	unprognostic (1.77e-2)	unprognostic (7.69e-2)	unprognostic (4.32e-2)	8.8	3.8	3	6.8	8.1	14.5	4.2	0.9	5	2.7	4.2	4	1.3	5	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0	0	0	0	0	2.7	0	0.2	14.2	12.9	0	1.4	3.1	0.8	0	3.7	0.2	0	0	0	0.3	0.2	20.1	0	0	0	0.7	1.4	0	0	0.1	0	0	0	2	4.9	0.1	0	0.1	11	3.7	0.3	0	1.1	3.5	0	0	0	0.4	0.3	0.5	0.2	0	1.7	0	0	1.3	0	0	0.2	0	0	3.3	0.4	0	0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3	8.1	0.9	5	3.3	3.9	3.2	5.7	3.6	0.4	3	6.9	2.7	0.8	0.3	1.6	1.4	0	4	0	1.8	0	2	1.7	2.4	2.5	4.7	5.3	70	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0	6.9	7.4	6.7	1.1	1.4	5.1	0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0	2	0.1	4.1	0.4	0.7	4.3	0.9	1.6	Erythroid cells
ABCB10	EST20237, M-ABC2, MTABC2	ENSG00000135776	ATP binding cassette subfamily B member 10	Q9NRK6	1	229516582-229558695	Plasma proteins, Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	9	Erythroid cells: 140.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HL-60: 42.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB044063, CAB044065, HPA055175	Uncertain											CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727	unprognostic (1.00e-1)	unprognostic (1.29e-2)	unprognostic (5.56e-3)	unprognostic (5.64e-2)	unprognostic (2.04e-1)	unprognostic (8.06e-3)	unprognostic (9.38e-2)	unprognostic (2.05e-1)	unprognostic (4.15e-2)	unprognostic (5.61e-2)	unprognostic (2.81e-1)	unprognostic (3.13e-1)	unprognostic (8.32e-2)	unprognostic (2.58e-1)	unprognostic (3.83e-1)	unprognostic (5.29e-2)	unprognostic (3.37e-2)	13.2	6.4	5.5	6.7	6	37.1	14	15.1	6.1	7.9	18.8	5.4	3.7	12.6	9.9	6.9	10.7	6.1	11.9	8.3	5.5	5.4	10.9	24.7	9.8	15.5	5.2	3.8	6.3	8.2	9	4.2	11.4	4.9	9.9	8.6	5.3	7.1	5.9	13.9	6	30.1	14.7	5	15	7.8	4	4.2	9.4	9.6	8.3	12.1	10	9.1	2.4	3.2	2.9	2.7	1.3	4.1	1.3	10.4	6.2	5.2	4.2	8.9	7.7	22.7	9.7	7.3	8.8	8	6.4	8	11.5	8.9	8.8	3.6	9.1	11.1	8	8.9	7.8	14.1	12.6	5.6	8.1	6.4	42.4	7.1	5.3	6.9	5.3	6.2	5.3	9.4	20.7	26.9	26.6	9	3.3	10.7	24.3	6.9	12.2	5.3	9.8	10.3	12.2	7.1	6.8	3.8	5.8	7.5	8.4	11.8	3.3	6.5	14.8	7.2	9.5	6	5.9	13.1	6.5	4.8	10	5	7.4	6	1.7	2.4	2.9	2.8	2.7	3.6	1.8	3.3	4.1	2.8	2.4	3	4	0.4	1.3	1.9	3.2	2.7	1.3	5.5	6	15.1	6.1	5.5	5.4	5.2	3.8	4.9	4.2	8.9	1.3	0.8	2.5	2.9	5.8	11.8	2.5	9.4	5.7	0	11.8	5.1	1.7	4.1	0	4.5	8	140.2	4.5	9.3	4.8	7.1	5.7	15.3	8.1	9.5	9.8	5.5	11	0.2	4.6	6.4	8.5	15.4	12.8	2.9	4.3	10.5	4.2	4.5	4.5	6.5	5.2	2.9	2.9	4.4	3	3.9	10.5	3.5	Erythroid cells
DNA2	DNA2L, KIAA0083	ENSG00000138346	DNA replication helicase/nuclease 2	P51530	10	68414064-68472121	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	DNA damage, DNA repair, DNA replication	DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease	Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	lymphoid tissue: 49.1	Cell type enriched	Detected in many	5	Erythroid cells: 70.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	6	NK-cell: 5.5	Lineage enriched	Detected in single	6	NK-cells: 5.5	Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all			HPA037487, HPA057526	Approved		Supported	Mitochondria		No	No			Mitochondria		HPA037487: AB_10672493, HPA057526: AB_2683456	unprognostic (1.79e-1)	unprognostic (1.35e-1)	unprognostic (4.37e-3)	unprognostic (4.60e-3)	unprognostic (1.53e-1)	unprognostic (1.86e-2)	unprognostic (4.50e-5)	unprognostic (3.36e-2)	unprognostic (4.70e-2)	unprognostic (3.72e-2)	unprognostic (1.30e-2)	unprognostic (3.29e-4)	unprognostic (1.09e-10)	unprognostic (3.43e-2)	unprognostic (1.98e-1)	unprognostic (9.36e-2)	unprognostic (1.23e-2)	1.6	1.2	2	13.7	2.4	7	3	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3	1.8	3.2	1	2.4	2	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5	1.9	2.4	1.1	2.3	4	1.7	3	5	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3	5.2	2.6	7	1.4	49.1	1.5	5.1	10.8	2.3	2	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.9	7.2	16.5	11.6	1.9	1.3	11.6	6.9	5.8	9.9	12.2	17.2	9.1	14.3	2.6	2.1	3.8	8.6	9.4	3.6	12	8.8	7.1	8.7	4.5	6.6	0.5	14.9	9.4	1	1.5	7	2.1	2.5	4.4	9.5	12.7	13	5.7	4.9	23	10.8	11.6	5.9	13.6	18	11.4	4.6	4.2	6.5	7.5	9	9.5	12.1	2.3	12.2	9.3	6.3	1.8	3.8	11.9	4.8	13.1	6.6	7.4	21.4	3.2	14.3	5	0	0	0.9	0.2	0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0	0.4	0.1	2	2.4	6.2	3.8	2.5	2.2	2.9	5	1.7	1.4	6	0.6	0	0.7	2.1	2.2	7.3	2.5	0	1.2	1.8	5.9	2	0	0.5	1.6	0.7	1.3	70	0.8	3.8	1.9	3.2	0	4.4	1.8	0	1.2	1.3	2.2	3.1	0.6	0	0	0	1.3	0.2	0.7	0	0.7	0.4	3.6	0	1	5	14.2	1.5	1	1.5	2.3	0.9	Erythroid cells
RANBP10	KIAA1464	ENSG00000141084	RAN binding protein 10	Q6VN20	16	67723066-67806652	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Erythroid cells: 93.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.64e-1)	unprognostic (1.35e-1)	unprognostic (3.37e-1)	unprognostic (2.46e-3)	unprognostic (4.51e-2)	unprognostic (8.00e-3)	unprognostic (9.04e-2)	unprognostic (2.27e-2)	unprognostic (1.31e-1)	unprognostic (4.06e-1)	unprognostic (2.77e-3)	unprognostic (7.46e-3)	prognostic favorable (7.52e-4)	unprognostic (2.80e-1)	unprognostic (1.17e-1)	unprognostic (1.17e-2)	unprognostic (2.16e-1)	10.8	21.9	11.8	14.5	11.4	44.4	14.1	29.9	14.8	11.2	10.2	10.6	25.3	9.1	14.1	11.3	14	16.6	10.3	11.4	10.1	8.1	12.7	29.1	17.7	15.5	8.3	13.4	16.5	13.9	17.3	12.4	16.8	9.5	12.2	10.5	11.4	12.3	34.3	31	17	10.5	12.7	9.3	16.8	9.5	9.7	11.1	13.1	11.2	10.8	13.2	9.6	13.5	2	3.4	3.2	2.6	2	3.7	1.8	6.3	8.9	8.9	8.8	10.8	6.1	13.8	5.9	10.2	11.4	11.3	9.2	5.7	10.8	8.6	6.3	4.4	9.8	9	7.9	9.3	5.8	7	4.5	7	7.9	8.4	9.1	25.6	6.4	9.2	10.2	11.3	8.7	10.3	14.3	12	3.4	5.8	9.2	8.5	9.4	7	7	4.8	14.9	5.6	8.8	6.3	7.7	6	6.7	28.5	5.4	10.5	6	11.2	8.7	8.9	6.5	6.5	7.9	6.3	7.6	9.4	17.4	5.8	9.7	10.1	0	2.2	3.2	2.4	2.6	3.7	1.6	2.7	2.2	3.4	2	2.1	3.2	1.1	2	2.2	2.7	3.6	1.8	11.8	11.4	29.9	14.8	10.1	8.1	8.3	13.4	9.5	11.1	11.9	6.2	4.2	2.8	3.9	5.2	6.9	7.6	14.7	3.4	1.8	15.7	4.6	3.3	6.5	3.2	5	5.3	93.5	4.3	3.3	3.1	4.6	0	18.7	4.8	9.5	4.7	9.2	6.7	3.9	4	2.6	0	5.4	8	3.9	5.6	7	3.5	2.9	9.5	0	2.3	4.8	4.1	4.8	7.1	1.5	5.6	3.1	Erythroid cells
SLC25A37	HT015, MFRN, MFRN1, MSCP	ENSG00000147454	Solute carrier family 25 member 37	Q9NYZ2	8	23528805-23575463	Predicted intracellular proteins, Transporters	Ion transport, Iron transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 88.8	Cell type enriched	Detected in all	5	Erythroid cells: 3550.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	18	neutrophil: 28.9	Lineage enriched	Detected in many	18	granulocytes: 28.9	Cell line enhanced	Detected in many		HEL: 47.7;hTERT-RPE1: 27.9	Low region specificity	Detected in all							HPA045680	Uncertain		Approved	Mitochondria,Cytosol						Mitochondria	Cytosol	HPA045680: AB_10963693	unprognostic (6.15e-3)	unprognostic (7.33e-3)	unprognostic (2.04e-1)	unprognostic (1.40e-1)	unprognostic (1.38e-1)	unprognostic (5.12e-2)	unprognostic (1.35e-1)	unprognostic (1.68e-1)	unprognostic (3.58e-2)	unprognostic (1.40e-1)	unprognostic (1.02e-2)	unprognostic (2.24e-1)	prognostic unfavorable (4.37e-6)	unprognostic (8.27e-2)	unprognostic (1.71e-1)	unprognostic (2.37e-1)	unprognostic (7.40e-2)	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8	15	8.6	1.9	9	5.9	5.7	13.9	33	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3	1	2.2	47.7	7	1.4	4.9	2.7	1.9	6.2	8	4.8	4.8	27.9	3.4	5	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35	24.5	60.7	19.4	95.7	12.5	47.1	47	15.3	22.7	43.1	139.3	Erythroid cells
SNX22	FLJ13952	ENSG00000157734	Sorting nexin 22	Q96L94	15	64151715-64157481	Predicted intracellular proteins	Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 23.2;thyroid gland: 41.1	Cell type enriched	Detected in many	5	Erythroid cells: 140.2	Cancer enriched	Detected in many	7	thyroid cancer: 47.7	Low region specificity	Detected in all			Group enriched	Detected in some	7	memory B-cell: 6.6;naive B-cell: 11.5	Lineage enriched	Detected in many	9	B-cells: 11.5	Cell line enriched	Detected in some	4	Daudi: 19.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038470			Approved	Nucleoplasm,Vesicles						Vesicles	Nucleoplasm	HPA038470: AB_10673174	prognostic favorable (2.89e-5)	unprognostic (8.93e-3)	unprognostic (2.89e-1)	unprognostic (3.55e-2)	unprognostic (3.24e-1)	unprognostic (5.38e-3)	unprognostic (2.29e-1)	unprognostic (3.05e-2)	unprognostic (1.94e-1)	unprognostic (5.29e-2)	unprognostic (2.28e-3)	unprognostic (1.09e-1)	unprognostic (1.27e-4)	unprognostic (3.92e-1)	unprognostic (2.52e-1)	prognostic favorable (2.19e-4)	unprognostic (1.74e-2)	1.1	1.5	11.9	7.6	8.9	10.2	1.2	3.4	16.5	0.7	1.1	23.2	11.8	1.5	1.2	3.5	0.9	0.8	1.3	7.9	13.4	9	1.1	1.9	4.7	11.4	13.7	8.1	1.3	1.6	0.4	2.2	1	12.3	3	0.7	0	3.6	8.4	0.7	2	2.2	0.9	17	6.1	2.1	1	6.6	1.6	41.1	0	13.3	2.1	0.3	11.5	1.2	0	0.2	0.1	0.1	1.6	0.2	0.4	0.9	0.8	0.1	0	0.7	0.8	0	0	0.2	0.4	0.9	19.9	0.5	0.1	0.5	0.4	1.7	0	0	0.1	2.4	0.4	2.2	2.5	0	0.4	0.4	0	0	0	0	0.7	0	2.5	0.6	3.3	0	1.2	0.2	0	1.4	0.5	0.3	4.1	0.3	1.2	0.8	0.8	4.6	0.9	0.2	0.7	0	0.8	2	0	0	1.1	1.4	0.3	0.5	4.3	1.8	4.3	0.5	0.1	0	0	0	0	0	0	0	6.6	0	0	1.2	11.5	0	0	0	0.1	0.2	0	0.1	1.6	11.9	8.9	3.4	9.3	13.4	9	13.7	8.1	12.3	6.6	26.8	9.1	15.2	1.7	1.3	0.8	14.2	0	0	1.2	0	3.9	2.7	0	0.4	1.1	0.7	0.7	140.2	3.2	6.1	3.6	3.9	2.3	3.4	4	0	0	2.5	2.2	1.7	0.6	2.7	3.3	1.8	0.8	0.5	1.8	0	0.4	1.8	1.8	0	1	1.1	1.2	2.5	3.3	2.1	0.6	1.4	Erythroid cells
ALAS2	ASB	ENSG00000158578	5'-aminolevulinate synthase 2	P22557	X	55009055-55031064	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Heme biosynthesis	Acyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	bone marrow: 130.9;placenta: 53.5	Cell type enriched	Detected in some	86	Erythroid cells: 1168.1	Low cancer specificity	Detected in single			Low region specificity	Detected in some			Cell type enriched	Detected in single	6	plasmacytoid DC: 2.0	Lineage enriched	Detected in single	6	dendritic cells: 2.0	Group enriched	Detected in some	87	HEL: 32.8;K-562: 36.8	Low region specificity	Detected in all			Low region specificity	Detected in some								Intracellular and membrane								unprognostic (7.82e-2)	unprognostic (2.01e-1)	unprognostic (6.41e-2)	unprognostic (1.14e-2)	unprognostic (2.98e-3)	unprognostic (5.59e-2)	unprognostic (1.37e-1)	unprognostic (1.47e-1)	unprognostic (8.68e-2)	unprognostic (4.07e-2)	unprognostic (2.72e-1)	unprognostic (3.45e-1)	unprognostic (2.32e-2)	unprognostic (6.63e-3)	unprognostic (4.39e-1)	unprognostic (1.23e-1)	unprognostic (1.89e-1)	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0	0.4	0.3	0.3	2.3	1	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1	53.5	2.3	2.6	0.3	1	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0	0.4	3.2	0	0.3	7	6.5	0.3	2	0.3	0.1	0	0.3	10.7	0	0	0	0.3	0	0	0.2	0	0	0	0	0.1	0.1	0	0	0	0	0.2	0	0	0	0	0.2	32.8	0	0	0	0.1	0.1	0	0	0	0	0	0	0	36.8	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0.2	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0.1	0	0.1	0	0.3	0.3	0	0	0.1	0.1	0	0.2	0.3	0	0	2	0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	5.8	0	0	0	1168.1	0.2	0.6	0.2	0	0	0.8	1.9	0	1.7	0	1.3	0	0	0	13.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	Erythroid cells
SPC24	FLJ90806, SPBC24	ENSG00000161888	SPC24, NDC80 kinetochore complex component	Q8NBT2	19	11131520-11155808	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 58.0	Cell type enriched	Detected in many	5	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in single			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli			Yes			Nucleoplasm	Nucleoli	HPA051234: AB_2681397	unprognostic (1.57e-1)	prognostic favorable (3.59e-4)	unprognostic (6.79e-2)	unprognostic (1.07e-3)	unprognostic (4.04e-1)	unprognostic (2.98e-2)	prognostic unfavorable (1.46e-4)	unprognostic (1.21e-2)	unprognostic (1.69e-2)	unprognostic (1.12e-2)	prognostic unfavorable (1.22e-4)	unprognostic (6.12e-2)	prognostic unfavorable (0.00e+0)	unprognostic (1.62e-2)	unprognostic (3.52e-2)	unprognostic (2.25e-1)	unprognostic (8.82e-2)	2.8	3.2	1.1	9	1	19.4	3.8	0.4	1.9	2.8	4	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1	0.4	1.8	2.6	4.2	4.9	0.6	1	1.1	1	0.1	1	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4	13.3	0.7	58	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9	20.8	17.6	6.8	8.5	14.3	10.6	11	10.8	11	9.1	28	23	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16	21.4	21	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1	0.4	1.9	1	0.4	0.6	1	0.6	0.7	0	0.3	0	0.8	1	0	7	2.5	0	1.2	5.2	5.9	3	0	0.2	0.1	0.1	0.7	70	0	13.5	4	0.3	5.7	0	11.2	0	2.4	2.5	2.8	1.7	0.6	1.3	0	0	1.1	0.9	0.2	0	0.4	0.4	0.3	0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4	Erythroid cells
CCNF	FBX1, FBXO1	ENSG00000162063	Cyclin F	P41002	16	2429394-2458854	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, Ubl conjugation pathway	Cyclin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 35.7	Cell type enriched	Detected in many	6	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA060596, HPA070495, HPA071600	Enhanced		Supported	Centrosome			Yes			Centrosome		HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424	unprognostic (3.87e-2)	unprognostic (2.21e-2)	unprognostic (1.57e-3)	unprognostic (3.70e-3)	unprognostic (1.24e-1)	unprognostic (1.13e-1)	prognostic unfavorable (7.46e-7)	unprognostic (2.45e-2)	unprognostic (1.75e-2)	unprognostic (1.99e-1)	unprognostic (1.01e-2)	unprognostic (1.58e-2)	unprognostic (0.00e+0)	unprognostic (1.22e-2)	unprognostic (1.10e-2)	unprognostic (4.25e-2)	unprognostic (2.74e-1)	2.1	1.8	4.1	6	3.2	9.2	5.1	11.6	4.9	2.1	3	1.9	3.6	4.4	1.5	3.4	8.1	1.5	1.5	1.8	4.3	3.9	1.7	1.6	2.2	10.5	1.9	3.1	1.8	1.7	0.8	1.8	3.8	2.4	3	3.2	0.7	3.2	3.4	2.5	7.2	3.2	1.8	1.7	4.7	2.6	5.1	2.3	35.7	1.6	3.4	14.2	5	2.9	2.7	1.4	0.1	1.1	4.1	3.1	1.7	8.4	13.4	12.9	11.8	0.8	1.2	10.1	10.2	5	14.3	11	26.6	10.4	17.9	3.5	5.7	4.2	14.4	21.3	7.9	6.8	12.7	10.1	19.6	13.9	8.1	1	12.8	12.9	0.8	1	10.1	4.8	1.8	10.6	15.1	20.8	11.7	7.2	18.4	18.7	8.5	12.7	9.1	6.1	31.4	15.1	16	3.9	3.7	12.5	7	15.2	13.3	2.8	6.7	14.2	6.6	7.3	7.9	20.5	5.6	10.6	7.2	8.6	30.9	2.3	12.8	10.7	0	1.1	0	2.8	0.6	1.7	2.7	1.5	3.1	0.5	2.6	1.2	1.7	0.1	4.1	0.9	1.4	2.2	1.7	4.1	3.2	11.6	4.9	4.3	3.9	1.9	3.1	2.4	2.3	0	4.6	0.8	2.1	2.5	4.6	1.7	0	0	2.3	1.8	11.8	0.8	0	1	0.8	1.3	0.7	70	0.5	10.5	0.9	1.2	1.1	0.8	5	7.9	1.2	1.8	1.6	0	1.7	1	5	1	1.9	0.6	0.9	0	2.5	0.2	1.3	0	2.7	2.1	5.1	1	1.6	1.5	1.8	1.4	Erythroid cells
TRIM58	BIA2	ENSG00000162722	Tripartite motif containing 58	Q8NG06	1	247857199-247878205	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2	Cell type enriched	Detected in many	16	Erythroid cells: 186.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA023637	Uncertain								310000			HPA023637: AB_1858309	unprognostic (3.85e-1)	unprognostic (5.24e-3)	unprognostic (7.00e-2)	unprognostic (6.52e-4)	unprognostic (1.46e-1)	unprognostic (3.47e-2)	unprognostic (1.10e-1)	unprognostic (4.14e-5)	unprognostic (3.59e-1)	unprognostic (2.07e-1)	unprognostic (1.27e-1)	unprognostic (5.00e-2)	unprognostic (3.31e-1)	unprognostic (1.08e-2)	unprognostic (3.34e-1)	unprognostic (1.00e-2)	unprognostic (2.57e-2)	0.7	0.8	1.3	1	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0	15.2	0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0	0	0	0	0.3	1.2	0	0.1	0	0	0	0	0	0	1.4	0	0.2	1	8	0	0	0	0.8	21.4	0	0	0	2.8	1.6	0	0	0.1	0	0	0	0.8	11.8	0.1	0	0	0	0.1	1.4	0	20.7	0	0	1.6	0	0	0	0	0	0.1	0	0.8	0.1	2.1	0	0	16.8	0	0	3.6	0	0	0	6.1	21.8	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1	3	4	1.7	0.6	0.9	2.3	0.4	0	6.7	10.3	1.8	11.8	2.4	0	0.1	3.1	0.8	0	186.9	0	3.3	1.5	2.9	8.1	0	2	0	1.2	1.8	2.6	0.5	0.9	1.6	1.7	0	0.4	1.5	0.2	0	0.7	0	3.5	0	0.8	2.8	10.9	0.6	4.1	1.3	0.8	0.9	Erythroid cells
SPTA1	EL2	ENSG00000163554	Spectrin alpha, erythrocytic 1	P02549	1	158610706-158686715	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell shape	Actin capping, Actin-binding	Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	bone marrow: 41.0	Cell type enriched	Detected in some	42	Erythroid cells: 70.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	K-562: 28.6	Not detected	Not detected			Not detected	Not detected			CAB016193, HPA028048, HPA028253, CAB037246	Enhanced								45000000			CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537	unprognostic (3.39e-1)	unprognostic (1.03e-1)	unprognostic (2.25e-2)	unprognostic (1.94e-1)	unprognostic (2.99e-1)	unprognostic (1.34e-1)	unprognostic (3.65e-3)	unprognostic (1.50e-3)	unprognostic (9.08e-2)	unprognostic (2.58e-2)	unprognostic (2.29e-1)	unprognostic (9.09e-2)	unprognostic (6.73e-8)	unprognostic (6.08e-2)	unprognostic (6.33e-2)	unprognostic (1.76e-2)	unprognostic (5.85e-3)	0.6	0	0	1.1	0	41	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0.7	4.1	0	0	0	0	0	0	2	8.1	0	0	0	0.5	0	0	0.4	0	0	0	0.6	4.6	0	2.2	0	0.3	0.9	0	0	0	2.8	0.9	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	6.5	0	0	0	0	0	0	0	0	0	0	0.3	0	28.6	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0.9	0	0	0	0.4	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	1.7	0	1.5	0.1	0	70	0	0.2	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Erythroid cells
CA3	CAIII, Car3	ENSG00000164879	Carbonic anhydrase 3	P07451	8	85373436-85449040	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	skeletal muscle: 347.5	Cell type enriched	Detected in some	14	Erythroid cells: 280.4	Group enriched	Detected in many	7	glioma: 23.1;prostate cancer: 9.4	Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.8	Low lineage specificity	Detected in single			Group enriched	Detected in some	9	HEL: 23.8;RH-30: 40.1	Low region specificity	Detected in some			Not detected	Not detected			CAB004967, HPA021775, HPA026700	Enhanced								31000000			CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991	prognostic favorable (4.24e-6)	unprognostic (1.40e-1)	unprognostic (1.50e-2)	unprognostic (2.22e-3)	unprognostic (4.71e-2)	unprognostic (8.43e-3)	unprognostic (3.56e-2)	unprognostic (4.04e-2)	unprognostic (1.11e-1)	unprognostic (3.68e-1)	unprognostic (4.71e-2)	unprognostic (3.54e-1)	unprognostic (3.19e-2)	unprognostic (1.18e-1)	unprognostic (9.96e-2)	unprognostic (1.39e-1)	unprognostic (2.19e-1)	18	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0	0.1	0.1	0.6	29	9.5	1	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0	0.1	0	0.1	0.1	0	0.3	0	0	6.6	0	0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0	0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0	0	0	0.8	0.2	0.9	0	0.5	0	0	0	0	0	0	0	0	0.4	0.5	0	0	0	0	0	0.1	0.1	0	0.2	0.1	23.8	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	3.7	0	0	40.1	0	0.7	0	0	0	0	0	0	0.7	0	0.9	0	0	0.3	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0.3	0	0.8	0	0	0	1.8	0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0	0	0	3	3.4	0	0.9	0.5	0	0.8	7.6	0	0	0	5.9	0.6	0	0.7	20.2	0	0.7	280.4	0.2	0	0.6	0.5	0	0	0.4	0	0	1.8	0.3	4.7	0.3	0	0	0	0.3	16	0.2	1.7	0	0.5	1.4	0	0.1	0.5	0.9	0.9	1.4	0	0.6	0.3	Erythroid cells
GFI1B	ZNF163B	ENSG00000165702	Growth factor independent 1B transcriptional repressor	Q5VTD9	9	132944000-132991687	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	blood: 71.0;bone marrow: 29.2	Cell type enriched	Detected in some	5	Erythroid cells: 70.0	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	basophil: 31.2;eosinophil: 71.0	Lineage enriched	Detected in many	26	granulocytes: 71.0	Group enriched	Detected in some	5	HEL: 55.6;HMC-1: 36.0;K-562: 17.1	Not detected	Not detected			Low region specificity	Detected in all			CAB004420, HPA006291	Enhanced		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		CAB004420: AB_2110132, HPA006291: 	unprognostic (1.79e-2)	unprognostic (2.90e-4)	unprognostic (6.54e-2)	unprognostic (1.76e-1)	unprognostic (2.33e-1)	unprognostic (1.54e-2)		unprognostic (2.53e-3)	unprognostic (1.05e-1)	unprognostic (2.47e-1)	unprognostic (1.54e-1)	unprognostic (4.61e-2)	unprognostic (3.71e-2)	unprognostic (2.17e-1)	unprognostic (2.53e-1)	unprognostic (1.53e-2)	unprognostic (1.41e-1)	0.2	0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0	0.1	0	0.1	0.2	0	0.1	1.2	0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1	0.2	3.3	0.3	4	0	1	0.2	0	0.5	0.4	0.2	0	0.3	71	2.7	0.1	0.1	2.4	0.2	0	0	0	0	0.2	0.1	0	0	0	0	0.6	0.1	7.8	0	0	0	0.6	0	0.2	0	0	0	55.6	0.1	0	0	0	36	0	0.6	0	0.1	0	0	0	17.1	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.5	0	0	0	31.2	0	71	0	0.3	0	0	0	0	0.3	0	0.1	0	0.8	0.1	2.7	0.1	0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0	0	0	0	1.1	0	0.2	0	0	0.8	0	0	3.4	0	0	0	0	0	2.6	0	0	70	0	0.1	0	0.5	13.9	0	0.1	0	1.2	0	0.8	9.3	0	0	0	0	0	0	0	14.4	0	0	0	0	0	0.3	0.5	0	0.2	0	0.3	0.1	Erythroid cells
EPB42	MGC116735, MGC116737, PA	ENSG00000166947	Erythrocyte membrane protein band 4.2	P16452	15	43197227-43221125	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell shape, Erythrocyte maturation		Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	bone marrow: 54.8;placenta: 16.1	Cell type enriched	Detected in many	15	Erythroid cells: 186.9	Not detected	Not detected			Region enriched	Detected in some	4	cerebellum: 4.3	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	92	HEL: 43.5	Not detected	Not detected			Low region specificity	Detected in all			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol					7500000	Nucleoplasm, Cytosol		HPA040261: AB_10673441	unprognostic (8.45e-2)	unprognostic (4.66e-1)	unprognostic (4.15e-1)	unprognostic (1.13e-1)	unprognostic (2.28e-1)	unprognostic (1.99e-1)	unprognostic (1.54e-1)	unprognostic (1.59e-3)	unprognostic (2.95e-1)	unprognostic (6.05e-2)	unprognostic (5.27e-3)	unprognostic (1.31e-1)	unprognostic (1.48e-5)	unprognostic (1.70e-2)	unprognostic (1.20e-1)	unprognostic (5.88e-2)	unprognostic (3.47e-3)	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0	0.3	0.2	0	0	0.1	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	43.5	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.3	0	4.2	0.4	0.9	4.3	1	0.4	0.9	0.5	0.3	0.7	0.3	0	0	0.5	1.2	1.6	3.7	0.3	2.5	0	0	0	5.9	3.3	0	0	7.7	0.6	1.1	186.9	0	1.9	1.7	1	4.6	0.5	1	6.4	0	1.3	0.3	8	2.6	0.8	1.7	0	0.8	2.8	0	1.7	0.7	0	7.8	6.5	1.2	12.1	3.8	2.5	5.6	4.4	0.6	1.6	Erythroid cells
AHSP	EDRF, ERAF	ENSG00000169877	Alpha hemoglobin stabilizing protein	Q9NZD4	16	31527864-31528803	Plasma proteins, Predicted intracellular proteins		Chaperone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	bone marrow: 189.3	Cell type enriched	Detected in some	394	Erythroid cells: 8947.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTCEpi: 7.7;K-562: 3.3;MOLT-4: 2.1;NTERA-2: 1.4					Low region specificity	Detected in all			HPA040940	Enhanced								8400000			HPA040940: AB_10796231		unprognostic (3.00e-1)			unprognostic (2.01e-1)	unprognostic (8.44e-2)	unprognostic (3.76e-1)	unprognostic (1.53e-1)		unprognostic (3.10e-1)	unprognostic (2.16e-1)		unprognostic (3.70e-3)	unprognostic (2.04e-2)	unprognostic (9.02e-2)	unprognostic (3.25e-2)		0.6	0.1	0.3	0.3	0.4	189.3	0.9	0	0.1	0.1	0.1	0.8	0	0.1	0.3	0.1	0.2	0.1	0.1	4	0.2	0.2	1	3.5	20	0.1	0.7	0	0.8	1.1	0.1	1.1	30.2	0.2	0.5	0.1	1	0.1	0.1	0.7	0.3	0.1	0.1	0.3	18.9	0.1	2.8	0.1	1.1	2.1	0	0.1	1.5	0.8	0.3	0.2	0.8	0.1	0	0.2	9.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	0	0	0	3.3	0	0	0	2.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0.1	0.2	0	0	0.2	0.8	0	0	0	0	9.2	0.3	0.4	0	0.1	0.2	0.2	0.7	0	0.2	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	22.7	0	0	8947.3	0.2	0	0	0	0	0	0	0	0	0	1.9	18	0.3	0	10.1	0	0	0	0	0	0	0	0	0	0	3.2	0.4	0	0	0	0	0	Erythroid cells
GYPA	CD235a, GPA, MN, MNS	ENSG00000170180	Glycophorin A (MNS blood group)	P02724	4	144109303-144140786	Blood group antigen proteins, CD markers, Predicted membrane proteins	Host-virus interaction	Blood group antigen, Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	bone marrow: 56.9	Cell type enriched	Detected in some	311	Erythroid cells: 1331.6	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	HEL: 57.0									CAB002658, HPA014811	Enhanced		Approved	Nucleoplasm,Plasma membrane,Cytosol						Nucleoplasm, Plasma membrane, Cytosol		CAB002658: , HPA014811: AB_1849827					unprognostic (1.60e-1)								unprognostic (2.47e-2)					0.1	0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0	0.3	4.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	6.2	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	57	0	0	0	0	0	0	0	0	0	0	0	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0.4	0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0.3	1.7	0	0.3	0	0	1331.6	0	1	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0.2	0	0	0	Erythroid cells
RFESD		ENSG00000175449	Rieske Fe-S domain containing	Q8TAC1	5	95646754-95684773	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 28.3	Cell type enriched	Detected in many	4	Erythroid cells: 163.5	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7	Cell line enhanced	Detected in many		HEL: 21.2;K-562: 39.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB016546	Uncertain		Approved	Nucleoplasm						Nucleoplasm		CAB016546: AB_630417	unprognostic (1.15e-1)	unprognostic (5.40e-2)	unprognostic (1.06e-1)	unprognostic (1.37e-2)	unprognostic (6.07e-3)	unprognostic (2.72e-1)	unprognostic (1.33e-3)	unprognostic (1.04e-1)	unprognostic (1.14e-1)	unprognostic (9.91e-2)	unprognostic (8.24e-3)	unprognostic (4.89e-2)	unprognostic (5.83e-3)	unprognostic (6.78e-2)	unprognostic (9.03e-2)	unprognostic (9.35e-2)	unprognostic (1.09e-1)	2.4	3.8	2.8	2.8	5.5	28.3	8.6	4.9	5.1	3.5	2.6	3.1	3.3	1.8	3.1	6.2	3.4	2.8	1.9	5.4	3.8	3.1	3.4	4.4	3.7	3.8	4.5	4.1	4.2	10.7	6.9	9.7	2.9	5.5	4.5	2.2	2.8	8.1	4.9	6.8	9.7	2.3	2.1	8.6	3.7	3.4	16	3.9	8.6	4.5	1.4	4.1	3.3	2.9	3.7	1.6	0.3	0.9	5	12.7	2.8	1.8	2.9	0.5	1.8	1.9	3.4	0	1	1.5	1.6	1.7	2.3	2	3	2.1	0.8	3.9	2.7	2	1.5	1.8	4.4	1.7	21.2	2.9	0.8	2.3	1.9	2.2	1.5	2.9	2.1	1.9	1.5	1.6	8.9	39.4	2.3	2.6	1.2	6.2	8.4	2.3	0.8	2.7	3	0.3	1.3	0.6	1.1	2.8	2	2.8	1.3	0	0.2	1.4	1	0.8	2.1	1.6	1.5	1.7	2.1	5	2.3	1.8	2.3	1.1	0	0.7	0.3	3.5	0.9	9.4	3.7	8.5	6	1.5	2.9	12.7	7.2	0	5	0.8	1.6	4.9	2.8	2.8	5.5	4.9	5.1	3.8	3.1	4.5	4.1	5.5	3.9	11.9	3.5	4.5	3.7	2.9	2.2	8.3	0	6.7	5.7	1.8	0	2.9	1.7	2	11.8	1.1	0.1	163.5	1.5	10.4	1.9	1.5	3.5	1.6	3.3	1.6	0	2.5	1	6.3	1.7	0.8	0	3.6	1	2.7	2.1	0	1.1	2.1	1.2	6.5	1.1	39.4	10.8	5.9	1.7	2.2	1.3	2.5	Erythroid cells
SLC25A21	ODC, ODC1	ENSG00000183032	Solute carrier family 25 member 21	Q9BQT8	14	36678431-37172866	Predicted intracellular proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 25.6	Cell type enriched	Detected in many	11	Erythroid cells: 93.5	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	K-562: 15.5;Karpas-707: 34.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000662	Uncertain											HPA000662: AB_1080000	unprognostic (6.81e-3)	unprognostic (6.98e-2)	unprognostic (7.21e-2)	unprognostic (2.45e-1)	unprognostic (2.78e-2)	unprognostic (2.20e-1)	unprognostic (2.44e-2)	unprognostic (1.09e-1)	unprognostic (7.32e-2)	unprognostic (6.86e-2)	unprognostic (9.16e-2)	unprognostic (1.66e-1)	unprognostic (6.70e-4)	unprognostic (9.09e-3)	unprognostic (1.95e-2)	unprognostic (3.52e-1)	unprognostic (1.07e-1)	1.3	2.1	1.1	1	2	8.8	1.4	0.4	2.5	3	1.9	0.7	0.1	1.1	4	1.4	2.9	1.8	1.2	2.2	1.1	1.4	2.8	1.1	1.9	0.1	1.4	0.7	4.6	5.2	0.9	1.8	0.4	1.7	3.1	0.4	3.6	2.9	0.9	9.6	0.9	2.4	3	1.2	0.9	2.6	25.6	1	0.2	3.3	2.2	1.3	1.3	1.4	0	0	0	0	0	0.3	0.1	0.8	0.7	0.2	2	0	0.6	0	0.3	0.5	1	0.4	0.1	0.7	0	0.9	0.2	0	0.7	0	0.4	0.4	0.5	5.9	0.6	0.6	0.6	0.6	0	0	0.5	0.8	0	0.3	0.6	2.4	0	15.5	34	0.5	1.8	0	0	1.3	0	2.5	0	0	0	0.5	2.4	1.5	0	1.6	0.1	0.8	0.3	2.2	0	1.1	0	1	0	0	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	1.1	2	0.4	2.5	1.1	1.4	1.4	0.7	1.7	1	0	0	0	1.7	0.9	0	1	0	0	0	0	0	0	1.7	0.7	1	0.4	0	93.5	8.3	0	0.8	2.3	0	0	0.2	1.6	1.7	1.3	0	0	1.4	0	0	0	0.2	3.4	5.4	0	0.7	3.1	1.5	0	1	3	2.1	0.6	0	0	0.8	0.6	Erythroid cells
RHD	CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI	ENSG00000187010	Rh blood group D antigen	Q02161	1	25272393-25330445	Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters		Blood group antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 10.0;bone marrow: 16.5;salivary gland: 7.1	Cell type enriched	Detected in some	20	Erythroid cells: 23.3	Not detected	Not detected			Low region specificity	Detected in some			Cell type enhanced	Detected in many		neutrophil: 10.0	Lineage enriched	Detected in many	5	granulocytes: 10.0	Group enriched	Detected in some	6	HEL: 28.2;K-562: 8.7									HPA060951, HPA077385	Supported		Uncertain	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA060951: , HPA077385: 	unprognostic (4.75e-3)	unprognostic (7.70e-2)	unprognostic (1.34e-1)	unprognostic (1.38e-1)	unprognostic (1.09e-2)	unprognostic (4.84e-2)	unprognostic (1.11e-2)	unprognostic (5.25e-2)	unprognostic (1.11e-2)	unprognostic (1.91e-1)	unprognostic (1.27e-2)	unprognostic (1.89e-1)	unprognostic (4.96e-3)	unprognostic (1.93e-1)	unprognostic (8.09e-2)	unprognostic (5.53e-2)	unprognostic (4.92e-3)	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2	0.6	10	1.4	1.4	1.4	1.2	0.1	0	0.2	0.2	0.1	0	0.4	0.1	0.1	0.1	0	0.1	0.3	0.4	0.1	0	0.1	0.2	0	0	0	0.5	0.1	28.2	0.7	0.2	0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0	0.1	0.2	0.2	3.1	0	0.1	0.2	0.1	0.1	0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1	0.6	1.1	1.3	1.3	0.8	0.2	2	1.4	1.3	10	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0	0.3	0	0.1	0.1	0.2	0.8	0	0	1.2	0	0	0	0	0	0.2	0.3	0	23.3	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0	Erythroid cells
C17orf99	GLPG464, UNQ464	ENSG00000187997	Chromosome 17 open reading frame 99	Q6UX52	17	78146353-78166177	Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Immunity	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	bone marrow: 13.5	Cell type enriched	Detected in some	53	Erythroid cells: 93.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		naive B-cell: 1.2;non-classical monocyte: 1.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	11	HaCaT: 5.6;HMC-1: 11.6;K-562: 6.5									HPA029655	Uncertain				Secreted to blood							HPA029655: AB_10601691	unprognostic (3.55e-5)	unprognostic (1.87e-2)	unprognostic (2.06e-1)	unprognostic (1.22e-1)	unprognostic (1.88e-1)	unprognostic (1.45e-3)	unprognostic (1.47e-3)	unprognostic (2.39e-1)	unprognostic (3.86e-1)	unprognostic (9.77e-2)	unprognostic (2.05e-2)	unprognostic (5.13e-2)	unprognostic (1.38e-4)	unprognostic (6.58e-2)	unprognostic (4.72e-2)	unprognostic (2.66e-1)	unprognostic (5.78e-3)	0.2	0	0.1	0.1	0.1	13.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.7	0.9	0.1	0.1	0.1	0	0.1	0.1	1.6	1.2	0.1	0.1	0.6	0.1	0	0.1	1.9	0.1	0.2	0	0.1	0.4	0.1	0.1	2	0.6	0.1	0.1	1.3	0	0.1	0.1	0.1	0.1	0.1	1.1	1.9	0.9	1.2	0	0	1.1	0	0.3	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	5.6	0	0.7	0	0	0	0.2	0.3	0.5	0	0	11.6	0	0.1	0	0	0	0	0	6.5	0	0	0	0.4	0	0	0.1	0	0	0	0.3	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.6	0	0	0	0	0	0	0	0.5	0	0	0	1.2	0	0.3	0	0	1.1	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	1.2	0.1	0.7	0	0	0	1.2	1.8	0	0.1	0	0	0	0	0	93.5	0.4	0.4	0.4	0.5	0	0	0.5	0	0	0.6	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0.9	0.1	0.1	0.6	0.2	0	0.1	0.6	Erythroid cells
HBA2	HBA-T2	ENSG00000188536	Hemoglobin subunit alpha 2	P69905	16	172876-173710	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport		Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 427.1;bone marrow: 1094.2	Cell type enriched	Detected in many	20	Erythroid cells: 168432.0	Cancer enhanced	Detected in all		glioma: 59.7	Low region specificity	Detected in all			Group enriched	Detected in many	6	eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7	Group enriched	Detected in many	8	dendritic cells: 15.7;granulocytes: 33.6	Group enriched	Detected in some	18	HEL: 161.2;K-562: 43.2									CAB038417, HPA043780	Enhanced								17000000000			CAB038417: , HPA043780: AB_2678667	unprognostic (1.57e-1)	unprognostic (7.02e-2)	unprognostic (2.59e-2)	unprognostic (2.13e-1)	unprognostic (3.59e-1)	unprognostic (3.18e-1)	unprognostic (3.39e-2)	unprognostic (2.12e-1)	unprognostic (4.99e-2)	unprognostic (4.43e-1)	unprognostic (1.09e-2)	unprognostic (1.19e-2)	unprognostic (1.72e-3)	unprognostic (1.36e-1)	unprognostic (2.11e-1)	unprognostic (4.73e-2)	unprognostic (8.92e-2)	15.4	11.8	7.2	6.9	7.3	1094.2	7.6	4.1	4.1	4.1	4.1	4.1	4.1	1.1	4.1	4.1	4.1	7.7	5.8	19.5	5.8	6.2	24.3	17.7	38.4	4.1	11.2	4.1	4.1	4.1	0.5	8.9	128.7	4.1	4.1	1.3	4.1	9.2	5.6	17.7	0.9	4.1	4.1	9.3	98.3	1.9	4.1	4.1	4.1	12.5	4.1	4.1	4.1	20.1	1.4	15.7	33.6	0.9	1.5	3	427.1	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0.2	0.6	0	0	0	0	0	0	0	0	161.2	0	0	0	0	0.2	0	0	0	0	0	0	0	43.2	0	0	0	0	0	0	0	0	0	0	5.7	0	0.1	1.6	1.3	0.1	0	0	0	0.2	0	0.7	0	0	0	0	0	0	0	0	0	0	3.5	0.9	9.8	3	0	0.1	1.4	0.3	0.2	1.4	0.8	0.8	2.6	33.6	1.5	0	15.7	0	427.1	7.2	7.3	4.1	4.1	5.8	6.2	11.2	4.1	4.1	4.1	3	1	72.9	0.1	39.4	1.2	4	12.7	4	1.2	0	0	0	46.4	0	2.6	9	1	168432	0	0	2.1	0.2	1.1	54.4	0	0	2.9	39.9	114.1	9.4	0	1.1	8337.5	0	1.3	1.3	0	3.7	0	12.3	41	0	364.9	0.2	6.6	39	0	20.8	0.7	0	Erythroid cells
RHCE	CD240CE, RH	ENSG00000188672	Rh blood group CcEe antigens	P18577	1	25362249-25430192	Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters		Blood group antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	4	bone marrow: 40.5	Cell type enriched	Detected in some	33	Erythroid cells: 210.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 2.4	Lineage enriched	Detected in single	7	granulocytes: 2.4	Cell line enriched	Detected in some	5	HEL: 44.7									HPA060951, HPA077385	Supported		Uncertain	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA060951: , HPA077385: 	unprognostic (1.37e-1)	unprognostic (3.53e-1)	unprognostic (2.38e-1)	unprognostic (6.75e-2)	unprognostic (1.41e-2)	unprognostic (4.91e-2)	unprognostic (7.01e-2)	unprognostic (3.12e-2)	unprognostic (3.81e-2)	unprognostic (1.35e-1)	unprognostic (6.08e-2)	unprognostic (4.61e-2)	unprognostic (5.77e-5)	unprognostic (1.38e-1)	unprognostic (3.94e-2)	unprognostic (7.15e-3)	unprognostic (1.63e-1)	0.6	0.8	2	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1	2.1	2.5	0.9	9.6	0.5	4	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0	0.1	0.2	0.4	0.3	0	0.1	0.1	0.2	0	0	0.7	0.3	0.5	0.5	0	0.1	0	0.1	0.1	0.2	0	44.7	0	0	0.6	0	0.3	1	0.7	0.3	0.2	0	0	0.3	8.7	0.2	0.2	0.4	0	0.3	0.9	0.3	0.2	0.1	0.1	1.2	0	0	0.3	0.4	0.1	0.1	0.5	0.4	0.2	0	0	0.1	0	0.4	0	2.6	0.6	0.5	1.5	0.4	0.2	2.4	0.2	0.6	0.3	0	0.3	0.1	0	0.1	0.2	0	0.2	0	1	0.1	0	0.1	0.3	0.9	2	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4	0	0	0	0.5	0.5	3.3	0.4	2.5	0	0	0	0	0.7	0	0.3	0.8	0	0	210.2	0.2	0.4	0.2	0.4	4.6	0.4	0.2	6.4	0	0	0	0	0.6	0	0	0	0	4.1	0.4	0	0.7	0	2.5	6.5	0	2.8	5.1	1.3	0.7	0	0.1	0.7	Erythroid cells
GYPE	GPE, MNS	ENSG00000197465	Glycophorin E (MNS blood group)	P15421	4	143870867-143905563	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		bone marrow: 14.5;lymphoid tissue: 6.9	Cell type enriched	Detected in some	5	Erythroid cells: 70.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 3.5	Group enriched	Detected in many	12	B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3	Group enriched	Detected in some	11	HEL: 50.9;K-562: 16.4																						unprognostic (2.17e-1)	unprognostic (6.03e-2)	unprognostic (2.66e-1)	unprognostic (1.00e-2)	unprognostic (4.71e-2)	unprognostic (1.09e-4)	unprognostic (2.05e-2)	unprognostic (1.29e-1)	unprognostic (6.77e-2)	unprognostic (1.10e-1)	unprognostic (1.53e-2)	unprognostic (2.81e-3)	unprognostic (1.10e-4)	unprognostic (7.81e-3)	unprognostic (1.76e-1)	unprognostic (2.97e-1)	unprognostic (3.49e-2)	2.7	0.2	1.2	1.5	0.5	14.5	1.2	0.5	1.2	0.9	0.5	0.5	0.5	0	0.5	0.8	0.5	0.1	0.7	2.6	1.1	0.3	0.7	0.5	3.7	1	0.5	0.5	1.5	0.5	0	0.5	5.7	1.1	0.5	0.4	0.5	0.5	0.6	0.5	0.5	1.7	0.5	0.7	6.9	0.4	0.8	0.5	1.5	1.4	0.5	3.1	0.9	0.5	3.5	0.1	0	0	2.1	1.3	0	0	0	0	0	3	3	0	1.2	2.7	0.6	0.8	0	0	0	0	1.5	0	0	0	0	0.7	0	0	50.9	0	0	0.6	0	0	0.3	0	0	0	0.7	0	0	16.4	0	0	0	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.5	0	0	1.5	0	0	0	0	0	0	0	0	0	0	1.3	3.5	0	0	0	1.1	0.8	0.6	0	2.1	0	0.1	0	0	1.2	0.5	0.5	1.2	1.1	0.3	0.5	0.5	1.1	0.5	14.9	1	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	70	0	0.1	0.3	0	0	0	0.2	0	0	0	0.6	0	0	0.1	3.3	0	0	0	0	0	0.7	0	0	0	0.1	0.7	0.2	0	0.1	0	0	0	Erythroid cells
CR1L		ENSG00000197721	Complement C3b/C4b receptor 1 like	Q2VPA4	1	207645113-207738416	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		bone marrow: 6.1;brain: 4.3	Cell type enriched	Detected in some	19	Erythroid cells: 93.5	Cancer enhanced	Detected in some		testis cancer: 1.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 3.1;HMC-1: 7.8;K-562: 3.8									HPA049348	Approved				Intracellular and membrane							HPA049348: AB_2680723	unprognostic (2.35e-2)	unprognostic (8.27e-2)	unprognostic (1.99e-1)	unprognostic (8.89e-2)	unprognostic (1.31e-2)	unprognostic (5.50e-2)	unprognostic (2.01e-1)	unprognostic (7.45e-2)	unprognostic (5.27e-2)	unprognostic (8.21e-3)	unprognostic (7.94e-2)	unprognostic (3.02e-1)	unprognostic (6.33e-2)	unprognostic (2.02e-1)	unprognostic (8.90e-2)	unprognostic (1.31e-2)	unprognostic (9.68e-2)	0.4	0.3	0.2	1.3	2.5	6.1	0.2	0.2	4	0.7	0.3	0.9	0.9	0.1	0.2	0.1	0.2	1.3	0.1	0.2	0.8	0.2	3.2	0.8	2.8	1.3	1	1.7	0.9	0.2	0.1	0.2	2.6	1.1	0.3	0.2	0	0.9	1	0.2	0.2	0.6	0.1	4.3	1	0.2	0.2	3.3	0	0.3	0	0.8	0.2	0.2	0.4	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	7.8	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.9	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0.2	0	0.4	0	0	0	0.2	0	0	0.5	0	0	0	0	0	0.2	2.5	0.2	4	0.8	0.2	1	1.7	1.1	3.3	0	0	0	0.1	0	0	0.4	0	0	0	1.8	0	0.1	5	0.4	0	0.1	0	93.5	0	0.2	0	0.3	0	0	1	0	0	1.8	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0.1	Erythroid cells
KEL	CD238, ECE3	ENSG00000197993	Kell blood group, metallo-endopeptidase	P23276	7	142941114-142962681	Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Blood group antigen, Hydrolase, Metalloprotease, Protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	bone marrow: 21.1;testis: 36.4	Cell type enriched	Detected in some	14	Erythroid cells: 46.7	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Cell type enriched	Detected in single	7	intermediate monocyte: 1.4	Lineage enriched	Detected in single	14	monocytes: 1.4	Group enriched	Detected in some	12	HEL: 15.3;K-562: 12.4	Not detected	Not detected			Not detected	Not detected			HPA064442			Supported	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA064442: 	unprognostic (5.78e-3)	unprognostic (1.08e-5)	unprognostic (5.29e-3)	unprognostic (4.85e-3)	unprognostic (9.68e-2)	unprognostic (1.96e-2)	unprognostic (1.03e-1)	unprognostic (1.54e-2)	unprognostic (5.18e-2)	unprognostic (1.08e-2)	unprognostic (3.71e-2)	unprognostic (3.57e-2)	unprognostic (2.29e-3)	unprognostic (9.24e-2)	unprognostic (7.05e-2)	unprognostic (3.32e-2)	unprognostic (3.25e-3)	0.2	0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5	2	0.2	0.2	0.2	0	0.2	1.1	0.3	0.2	0	0.3	2.5	0.2	0.2	0	0.5	0.2	4.4	3.8	0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0	0	0	1.4	0	0	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	15.3	0	0	0	0	0.1	0	0	0	0	0	0	0.2	12.4	0.1	0	0	0.5	0.3	0.3	0	0	0.1	0	0.1	0	1.2	0	0.1	0.2	0	0.5	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2	0.2	0.3	0.3	0	0	0	0.8	0	0	0.3	0	0	2.3	3.5	0	0	1.7	0.2	1.9	0	0	46.7	0	0.2	0	0.2	0	0	1	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0	0	1	Erythroid cells
IFIT1B	bA149I23.6, IFIT1L	ENSG00000204010	Interferon induced protein with tetratricopeptide repeats 1B	Q5T764	10	89378056-89385205	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	bone marrow: 23.2;placenta: 14.6	Cell type enriched	Detected in single	1635	Erythroid cells: 163.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7									HPA062924	Approved											HPA062924: AB_2684906	unprognostic (2.59e-1)	unprognostic (3.13e-1)			unprognostic (6.62e-3)	unprognostic (4.55e-2)			unprognostic (4.11e-2)	unprognostic (9.34e-2)			unprognostic (1.76e-1)	unprognostic (6.86e-2)				0.4	0	0.2	0	0.2	23.2	0	0	0.1	0.2	0	0.2	0	0	0	0.5	0	0.1	0	0.2	0.3	0.1	0.2	0.5	4	0	0.2	0	0	0	0	0.2	14.6	0.2	0	0	0.2	0	0	0	0	0	0	0.7	4.6	0	0.1	0	0.7	0.2	0	0	0.6	0	0.2	0	0.9	0.2	0	0.1	2.4	0	0	0.1	0.2	0	0	0	0	0	2.1	1.7	0	0.1	0	0.2	0	0.3	0.2	0	0	0.2	0	0	0.2	0	0	0	0	0	0.3	0	0.4	0.3	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0.1	0.5	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0.2	0.1	0	0.9	0	0.2	0	0	2.4	0.2	0.2	0	0.1	0.3	0.1	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	163.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Erythroid cells
TRIM10	HERF1, RFB30, RNF9	ENSG00000204613	Tripartite motif containing 10	Q9UDY6	6	30151945-30160934	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8	Cell type enriched	Detected in some	12	Erythroid cells: 70.0	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	11	EFO-21: 1.9	Not detected	Not detected			Region enriched	Detected in single	18	hippocampal formation: 4.0	HPA043325	Uncertain											HPA043325: AB_2678428		unprognostic (2.98e-1)	unprognostic (3.13e-2)	unprognostic (2.99e-2)		unprognostic (2.13e-1)	unprognostic (2.98e-1)	unprognostic (9.53e-3)	unprognostic (6.32e-2)	unprognostic (2.71e-1)	unprognostic (2.64e-2)		unprognostic (1.74e-3)	unprognostic (1.46e-2)	unprognostic (4.37e-2)		unprognostic (1.22e-2)	0	0	0	0.3	0	0	0	0	0.5	0.6	2.6	0	0	0	0	0	0	0	0	0	0	0	3.1	5.9	0.7	0	0	0	0.7	0	0	0	5.8	0	0	0	0.6	0	0	0.9	1	3	0	0	1.4	0.1	0.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	3.3	70	0	0	0	0	0	1.5	0.1	0	1.2	0	0.3	0	0	0	0	0	1.7	0	0.3	5.8	0	3	0	0	0	0	0	0	0.1	0	1.1	0	Erythroid cells
HBA1	HBA-T3	ENSG00000206172	Hemoglobin subunit alpha 1	P69905	16	176680-177522	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport		Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	bone marrow: 1020.7	Cell type enriched	Detected in many	24	Erythroid cells: 99681.0	Cancer enhanced	Detected in many		glioma: 6.3	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 11.7;plasmacytoid DC: 7.4	Group enriched	Detected in many	4	dendritic cells: 7.4;granulocytes: 11.7	Group enriched	Detected in some	37	HEL: 248.9;K-562: 175.4									CAB032534, HPA043780	Enhanced								17000000000			CAB032534: AB_2294993, HPA043780: AB_2678667	unprognostic (1.16e-1)	unprognostic (1.45e-2)	unprognostic (8.87e-2)	unprognostic (9.78e-3)	unprognostic (3.02e-1)	unprognostic (1.44e-1)	unprognostic (1.67e-1)	unprognostic (1.35e-1)	unprognostic (6.21e-3)	unprognostic (1.92e-2)	unprognostic (1.64e-1)	unprognostic (1.02e-2)	unprognostic (3.59e-2)	unprognostic (3.79e-1)	unprognostic (6.61e-2)	unprognostic (2.67e-2)	unprognostic (9.56e-2)	12.6	8.8	7.1	5	6.6	1020.7	5	7.9	10	2.2	3.2	3	2.2	1.3	2.2	4.1	2.8	4.8	4	16.9	5.2	5.1	20.6	15.7	30.3	8.1	10.1	5.8	4.9	2.2	0.9	7.5	104.1	3.3	4.8	1.4	4.5	6.7	3.3	9.4	1.9	2.2	5.1	7.9	101.4	1.6	6.7	2.2	2.2	9.3	2.2	2.2	3.4	9.4	0.6	7.4	11.7	0.5	0.9	2.1	186.1	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0.4	0.1	0	0	0	0.2	0	0	0	0	248.9	0	2.7	0	0.1	0	0	0	0	0	0	0	0.1	175.4	0	0	1	0	0	0	0	0	0	0.1	5.8	0	0	0.5	0.4	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.5	0.5	3.3	1.9	0	0	0.6	0.2	0.7	0.7	0.4	0.7	2.1	11.7	0.9	0	7.4	0	186.1	7.1	6.6	7.9	10	5.2	5.1	10.1	5.8	3.3	2.2	0	0	18.2	0	9.4	0.2	0.8	2.5	0	0	0	0	0	6.6	0	4.6	0.5	0.7	99681	0	0	0	0.1	0	30.9	0	0	1.2	17.2	53	11.2	0	0	4114.8	0	0.9	0.3	0.1	1.7	0.4	3.7	14.8	0	179.2	0.1	5.1	11.5	0	21.3	1.4	0	Erythroid cells
HBM	HBAP2, HBK	ENSG00000206177	Hemoglobin subunit mu	Q6B0K9	16	153892-166768	Predicted intracellular proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	bone marrow: 109.8;placenta: 50.2	Cell type enriched	Detected in some	740	Erythroid cells: 12474.7	Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		SCLC-21H: 2.3					Low region specificity	Detected in some												400000								unprognostic (1.30e-1)										unprognostic (7.59e-2)			0.9	0.2	0.4	0.2	0.5	109.8	0.3	0.1	0.2	0.2	0.2	0.5	0	0.2	0.2	0.2	0.6	0.2	0.2	4.4	0.3	0.4	1.7	2.6	16.5	0.2	0.7	0	1.6	0.2	0.2	1.1	50.2	1.2	0.5	0.2	1.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	17.5	0.2	0.2	0	1	2	0.1	0.3	2.1	4.9	0.1	0.5	0.5	0	0.9	0.4	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0	0	0.1	0	0	0	0.9	0	0.5	0	10.5	0.4	0.5	0.1	0.2	0.3	0.4	0.7	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12474.7	0	0	0	0	0	0	0	0	0	0.6	1	0	0	0	16.9	0	0	0	0	0	0	0	0	0	1.9	0	2.3	0.1	0	0	0	0	Erythroid cells
MXD3	bHLHc13, MAD3	ENSG00000213347	MAX dimerization protein 3	Q9BW11	5	177301461-177312757	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 32.1;lymphoid tissue: 59.4	Cell type enriched	Detected in many	7	Erythroid cells: 116.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 14.1	Group enriched	Detected in many	6	granulocytes: 14.1;monocytes: 8.7	Cell line enhanced	Detected in many		HDLM-2: 59.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA070111			Approved	Nucleoplasm,Nucleoli			Yes			Nucleoplasm, Nucleoli		HPA070111: AB_2686228	unprognostic (2.78e-1)	unprognostic (1.32e-2)	unprognostic (2.11e-1)	unprognostic (3.63e-1)	unprognostic (8.26e-2)	unprognostic (6.18e-3)	prognostic unfavorable (3.60e-4)	unprognostic (3.32e-1)	unprognostic (6.84e-2)	unprognostic (3.12e-2)	unprognostic (4.97e-2)	unprognostic (2.84e-2)	unprognostic (3.33e-16)	unprognostic (8.55e-3)	unprognostic (2.22e-1)	unprognostic (1.61e-1)	unprognostic (3.22e-3)	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2	1.6	14.1	8.7	0.7	0.8	1.1	8.1	5.6	3.5	9.5	0.2	0.5	5.8	10.6	3.5	4.8	4.6	3.7	8.5	4.3	4.4	1.4	2.6	4	0.4	1.2	0.2	59.2	7.2	2.4	8.1	5.4	0.5	2.3	7.5	0.3	0.6	0.3	0.2	0.4	4.4	19.2	1.5	13.6	0.9	10.4	21.6	6.5	1.2	2.5	9.8	10.6	10.8	6.2	1	1.1	8.6	7.1	6.8	6.9	3.7	0.5	10.9	6.2	3.2	5.8	15	4.6	5.6	18	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0	1.6	0.1	0.1	1.6	2	0	0.3	14.1	0.7	8.7	1	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9	3	2.2	0	1.5	4.9	2.8	1.2	5.1	5.3	4.5	5.2	0	4.5	0	1.3	16.3	2.3	4	116.8	3.5	7.2	3.4	2.4	9.2	3.9	8.8	3.2	1.7	4.3	4.9	1.9	1.7	5.1	3.3	1	5	1	1.9	3.1	1.4	0.3	2.2	0	3.1	0.7	5.9	5	11	5.1	6.9	1.8	Erythroid cells
HBD		ENSG00000223609	Hemoglobin subunit delta	P02042	11	5232678-5243657	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	bone marrow: 233.7	Cell type enriched	Detected in some	231	Erythroid cells: 15231.4	Not detected	Not detected			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 31.3;U-266/70: 42.6									CAB037087, HPA043234	Supported								11000000000			CAB037087: AB_260051, HPA043234: AB_2678378	unprognostic (1.32e-2)		unprognostic (4.87e-2)		unprognostic (4.14e-2)	unprognostic (2.26e-3)		unprognostic (1.52e-1)		unprognostic (3.56e-2)	unprognostic (1.04e-1)		unprognostic (8.67e-2)	unprognostic (2.83e-2)	unprognostic (3.17e-1)	unprognostic (6.24e-2)	unprognostic (3.17e-1)	1.6	0.2	0.4	0.3	0.6	233.7	0.8	0.1	0.5	0.2	0.2	1.5	0	0.2	0.4	0.2	0.9	0.5	0.2	4.3	1.3	0.4	1.4	3.9	22.5	0.2	1	0	1.1	0.2	0.2	1.3	12	0.8	0.5	0.2	1	0.9	0.2	1	0.2	0.2	0.2	0.4	29.6	0.2	0.2	0	1.2	4.4	0	0.4	1.7	11.9	0	0.5	0.8	0	0	0	31.6	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	31.3	0	0	0	0.1	7.3	0	0	0	0	0	0	0	3.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.6	7.5	0	0	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.5	0	31.6	0.4	0.6	0.1	0.5	1.3	0.4	1	0	0.8	0	0	0	0	0	0.2	0	0	0	0	0	1.8	0	0	0	0	0	0	0	15231.4	0	0	0.5	0	0	1.6	0.1	0	0	0.6	9.3	0	0	0	65.8	0	0	0	0	0	0	0.2	0	0	0.9	0	0	0.1	0	0	0	0	Erythroid cells
HBB	beta-globin, CD113t-C	ENSG00000244734	Hemoglobin subunit beta	P68871	11	5225464-5229395	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport	Hypotensive agent, Vasoactive	Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	7	bone marrow: 3646.7	Cell type enriched	Detected in many	16	Erythroid cells: 407904.6	Cancer enhanced	Detected in all		glioma: 244.6	Low region specificity	Detected in all			Group enriched	Detected in many	7	neutrophil: 19.3;plasmacytoid DC: 9.9	Group enriched	Detected in many	12	dendritic cells: 9.9;granulocytes: 19.3	Cell line enhanced	Detected in some		HEL: 5.5;SCLC-21H: 4.8;SH-SY5Y: 6.1;U-266/70: 22.3;U-266/84: 3.7									CAB009526, HPA043234	Enhanced								15000000000			CAB009526: AB_2143058, HPA043234: AB_2678378	unprognostic (2.41e-1)	unprognostic (8.55e-2)	unprognostic (2.40e-1)	unprognostic (4.40e-2)	unprognostic (1.14e-1)	unprognostic (3.22e-1)	unprognostic (4.88e-2)	unprognostic (7.46e-2)	unprognostic (2.91e-2)	unprognostic (1.76e-1)	unprognostic (1.91e-1)	unprognostic (8.11e-3)	unprognostic (2.40e-2)	unprognostic (5.81e-2)	unprognostic (1.42e-1)	unprognostic (8.87e-3)	unprognostic (6.41e-2)	32.7	20	20.9	10.1	21	3646.7	43.4	6.5	10.7	9.2	11.3	7.2	3.4	3.2	7.3	11.1	36.6	28.4	30.4	38.9	17.9	17.4	45	37.6	305.8	7	31.6	10.8	82.6	28.4	2.9	18.6	236.8	23.7	23.1	7.5	32	17.4	12.8	29.5	3.8	3.9	12	26.5	216.8	4	9.3	3.8	5.6	46.4	20.2	7.6	124.5	256.7	0.6	9.9	19.3	0.6	1.2	1.1	523.2	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	5.5	0	0	0	0.1	0	0	0	0	0	0	0	0	1.3	2.1	0	0	0	0.8	0.2	0.4	0	0	0.4	0.3	0	0	4.8	6.1	0.2	0	0	0	0	0	0	0	0	0.6	0	22.3	3.7	0	0	0	0	2.2	0.6	1.9	0.9	0	0.1	0.6	0.2	0	0.9	0.4	0.4	1.1	19.3	1.2	0.1	9.9	0	523.2	20.9	21	6.5	10.7	17.9	17.4	31.6	10.8	23.7	3.8	3	5.9	120	0	139.4	3.4	2	28.1	49.5	2.3	7	3.9	1.1	43.1	0	0	20.2	1	407904.6	0	2.3	16.4	0	0	226.1	6.6	3.2	3.5	92.1	289.2	0	0	2.3	25972.5	0	3.8	6.2	0.1	2.9	0	79.6	86.7	0	737.5	0	0	220.7	1.8	46.8	0.6	0	Erythroid cells
GYPB	CD235b, GPB, MNS, SS	ENSG00000250361	Glycophorin B (MNS blood group)	P06028	4	143996104-144019345	Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins		Blood group antigen		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	bone marrow: 37.1	Cell type enriched	Detected in some	591	Erythroid cells: 981.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	HEL: 61.4														Intracellular and membrane																									0.2	0	0.2	0.1	0.1	37.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.6	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0	0.2	3.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	6.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.4	0	0	0	0	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0	3.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	981.2	0	0.4	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Erythroid cells
HMBS	PBGD, PORC, UPS	ENSG00000256269	Hydroxymethylbilane synthase	P08397	11	119084866-119093549	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Heme biosynthesis, Porphyrin biosynthesis	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 75.2	Cell type enriched	Detected in many	16	Erythroid cells: 794.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006114, HPA050659	Supported		Approved	Lipid droplets					28000000	Lipid droplets		HPA006114: AB_1079067, HPA050659: AB_2681206	unprognostic (6.24e-2)	unprognostic (9.10e-3)	unprognostic (1.42e-2)	unprognostic (4.98e-2)	unprognostic (1.04e-1)	unprognostic (1.30e-1)	unprognostic (2.29e-3)	unprognostic (2.81e-1)	unprognostic (2.18e-1)	unprognostic (1.13e-2)	unprognostic (6.83e-2)	unprognostic (5.06e-2)	unprognostic (2.90e-3)	unprognostic (3.91e-3)	unprognostic (9.53e-2)	unprognostic (1.32e-1)	unprognostic (6.11e-2)	5.5	11	5.3	6.2	9.3	75.2	8.6	5.2	8	5.5	8.3	6	6	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6	8.4	13	9.3	5.7	4.8	7.7	19.1	12	14	3.8	7.4	9.4	9.2	14.1	6.8	12	5.4	6.8	10.2	7.4	8.3	10.9	9.4	17.5	14.7	14.3	16.6	9.4	10.3	13.2	10.1	14.4	7	9.8	10.4	23.6	5.7	12.8	10.1	8.8	7.7	7.4	9.2	17.2	13.2	4.8	5	13.5	34.9	6.4	8.6	37.2	8.5	17	7.6	17.1	9	9.9	6.7	14	11	8.5	7.5	10.2	5.9	9.3	6.5	5.1	15.9	12.2	4.7	8.3	6.3	8.1	8.6	3.5	4.1	8.5	5.5	11.6	9.8	12	14	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8	5.9	5.5	8.8	4.5	8.4	7.5	8.9	7	9.3	7.6	7	4.7	12.6	7.6	10.7	4.5	10.4	25.5	50.1	16.6	18.3	1.2	4.9	8.5	794.3	27	50.5	8.4	10.8	2.3	20.2	25.6	9.5	12.7	6.7	10.8	1.8	5.5	10.1	13.5	15.4	15.5	5.7	19.8	8.6	8.1	18.1	24.3	0	8.2	1.1	24.4	7	19.5	4.1	27.6	5.9	Erythroid cells
HIST1H2AH	dJ86C11.1, H2A/S, H2AFALii	ENSG00000274997	Histone cluster 1 H2A family member h	Q96KK5	6	27147129-27147515	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	13	lymphoid tissue: 301.1	Cell type enriched	Detected in some	5	Erythroid cells: 23.3	Low cancer specificity	Detected in some							Cell type enhanced	Detected in many		naive B-cell: 16.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2									CAB004030, HPA041189	Supported		Approved	Nucleoplasm			Yes			Nucleoplasm		CAB004030: AB_2118804, HPA041189: AB_2677357	unprognostic (4.07e-1)	unprognostic (2.73e-3)	unprognostic (4.04e-2)	unprognostic (4.01e-1)	unprognostic (2.02e-1)	unprognostic (5.35e-3)	unprognostic (3.90e-2)	unprognostic (3.20e-1)	unprognostic (2.36e-1)	unprognostic (2.38e-3)	unprognostic (2.91e-1)	unprognostic (2.32e-1)		unprognostic (9.74e-3)	unprognostic (1.87e-1)		unprognostic (1.26e-4)	0.8	0.7	0	26	0	20.2	1.5	0	0.4	3.1	6.6	0	0.6	1	1.8	2.6	6.4	1	2.7	1.3	0		0.5	0.4	4.1	5.4	0	0	2.4	0.5	0.4	0	9	0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0	13.9	0.7	23.5	0	301.1	0.6	9	27.3	1.9	0	16.2	2.2	0	2.4	5.1	4.7	2.3	2.6	3.5	1.1	4.9	0	0	0.7	0.3	0.6	0.6	0	2.6	1	3.8	0.9	0	0.6	0.3	1	0	0	2.1	9	4.7	3	0	0	3.2	1.8	0	0	1.2	0	0	0.9	1.8	4.8	2.4	0.9	0.4	9.3	10.2	3.2	0.9	1.2	3.4	3.1	5	0	0.3	2.5	0.6	1.4	0.5	0.2	0.1	1	1.5	0	0.8	2.8	0.2	2.7	2.9	2.9	6.1	1.3	4.6	0.8	0	0.9	0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0	5.1	1.5	1.5	0.8	2.3											0	0	0	1	0.2	0	0	0	0	3.4	0	0	0.7	0	0.3	1.7	0.1	1.6	23.3	0.3	1.9	0.3	0.8	1.1	0	0.7	0	1.7	1.8	1.2	4.3	0.6	0.6	0	0	0.3	0.2	0.1	0.9	0	0	0	0	0	0	4.5	0.5	0.2	2.5	1	0.6	Erythroid cells
HIST1H2AJ	H2A/E, H2AFE	ENSG00000276368	Histone cluster 1 H2A family member j	Q99878	6	27814354-27814740	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	22	lymphoid tissue: 357.7	Cell type enriched	Detected in some	29	Erythroid cells: 46.7	Low cancer specificity	Detected in many							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8					Low region specificity	Detected in some			HPA041189	Supported		Approved	Nucleoplasm			Yes			Nucleoplasm		HPA041189: AB_2677357	unprognostic (8.95e-3)	unprognostic (4.08e-3)	unprognostic (3.28e-2)	unprognostic (5.72e-3)	unprognostic (2.29e-2)	unprognostic (2.69e-2)	unprognostic (6.06e-2)	unprognostic (1.97e-2)	unprognostic (1.05e-1)	unprognostic (2.18e-1)	unprognostic (9.39e-3)	unprognostic (3.43e-1)		unprognostic (9.35e-2)	unprognostic (1.51e-1)		unprognostic (1.88e-2)	0.6	0.1	0	7.2	0	16.5	0.2	0	0.2	1	5.2	0	0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0		0.3	0.4	2.2	3.1	0	0	0.1	0.1	0.1	0	3.6	0	0.2	0.4	0	0.1	0.1	0.1	0.4	3.9	0.1	0	10.5	0.8	5.2	0	357.7	0.1	7.9	23.1	1.5	0	4.2	2.7	2.5	0.5	0.4	5.9	5	4	0	1.2	0	0	0	1	1.2	1.2	1.1	2.6	2.1	0.2	3.9	0.4	0.7	0.1	1.1	0	1.1	0.6	1.9	0.6	5.6	0.5	10	0.3	0	2.1	0	0.3	0.5	0.3	0	1.5	2.1	0	12.1	0.3	16.8	6.7	6.1	2	1.7	3.5	6	0	2.3	0.2	2.4	0.5	0.8	1.1	1.2	0.5	0.3	0.4	4.1	0	0	2.4	0.4	0.2	6.2	3.9	3.8	1.3	4.5	2.8	0	0.1	0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5											0	0	0	0.6	0	0	0	0	0	1.2	0	0	0.4	0	0	0	0	0	46.7	0	1.6	0	0.4	0	0	0.4	0	0	0	0.3	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0.5	0	0.6	0	0.4	0.3	Erythroid cells
ARHGAP11B		ENSG00000285077	Rho GTPase activating protein 11B	Q3KRB8	15	30624494-30638805	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		esophagus: 2.6;intestine: 2.7;stomach 1: 1.9	Cell type enriched	Detected in many	5	Erythroid cells: 93.5									Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 17.9									HPA064479	Uncertain		Uncertain	Vesicles						Vesicles		HPA064479: AB_2685272																		0.2	0		0		0.3	0		0	0	1.1			1.1	0	0	2.6	0.1	0	0			0	0.1	0.1	1.6			0	0	0		1		0	2.7		0	0	0	0.3	0.1	0		0.3	1.9	0.4			0		0.9	0.3		1	0.8	0	0	0	1.3	0	2.9	0.4	0	1.8	0.6	0.6	1.6	0.2	1	1.3	0.5	4.6	3.1	0	1.4	1	1.8	5.3	4.2	0.1	2.5	4.1	0.4	0	17.9	1.4	0.4	0.9	0.2	0.4	0.1	0.5	1.1	0.9	1.5	0	1.3	7.8	3.9	0.2	2.4	0.6	0.9	1.4	0.3	0.9	1.8	1.2	1.3	4.6	2.7	1	1.1	1.3	0.6	0.7	1.5	3.3	1.3	4.8	2.7	0.1	3	3	2.1	1.4	1.1	3.7	5	0	0	0	0.1	0	0	0.3	1.3	0.9	0.8	1	0.3	0.6	0	0	0	0.3	0.2	0											0	1	11.2	1	1.8	3.4	0.7	0	1.4	0	1.8	5.9	0	0	0.4	20.2	0.5	1.7	93.5	0.5	0	0.9	0.9	1.1	0.8	0	3.2	0	4.3	5.7	12.8	2	2.9	0	3.6	4	13.2	0.4	3.4	1.1	0.3	2.4	0	1	13.6	10	1.3	0	5.3	2.9	0.9	Erythroid cells
